The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity
-
Marco Salvatore
Abstract
Background: The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis started in 2001; public laboratories distributed throughout Italy participated on a voluntary basis.
Methods: The Italian Public Health Institute (Istituto Superiore di Sanità) sent six validated DNA samples to participating laboratories: technical and clinical information was provided for each sample. Laboratories were required to analyse all six samples. For each sample the laboratories had to provide the results (including raw data) and a report of molecular analysis within 2 months using current methods and nomenclature. Raw data and reports were evaluated by a Steering Committee and their comments were sent to each laboratory.
Results: Genotyping results indicated a general good level of quality for all laboratories, i.e., ∼1% of alleles were incorrectly assigned each year due to analytical (45%) and misinterpretation (45%) errors. During the first 2 years, more than 70% of laboratories did not test for some regional Italian mutations. Commercial kits for reverse dot-blot and oligonucleotide ligation assay PCR were used to detect mutations by 52.8% and 29.5%, respectively, of the participating laboratories. Reporting of results was still inadequate; in 2004 a model for the written report was introduced, but not all laboratories used it.
Conclusions: Our data show that few genotyping errors were made by laboratories and were principally due to misinterpretation and analytical reasons. However, reports are still inadequate and it will be interesting to evaluate the introduction of the reporting model in future years.
Clin Chem Lab Med 2007;45:254–60.
References
1. Dugueperoux I, De Braekeleer M, the Participating Centres to the French National Cystic Fibrosis Registry. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France. J Cyst Fibros2004;3:259–63.10.1016/j.jcf.2004.07.004Search in Google Scholar
2. Castaldo G, Polizzi A, Tomaiuolo R, Cazeneuve C, Girodon E, Santostasi T, et al. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in a southern Italian population. Ann Hum Genet2005;69:15–24.10.1046/j.1529-8817.2004.00130.xSearch in Google Scholar
3. Estivill X, Bancells C, Ramos C. The Biomed CF Mutation Analysis Consortium. Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. Hum Mutat1997;10:135–54.10.1002/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.0.CO;2-JSearch in Google Scholar
4. The CF mutation database. http://www.genet.sickkids.on.ca/cftr. Accessed January 15, 2007.Search in Google Scholar
5. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science1989;245:1073–80.10.1126/science.2570460Search in Google Scholar
6. Bobadilla JL, Macek M Jr, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations – correlation with incidence data and application to screening. Hum Mutat2002;19:575–606.10.1002/humu.10041Search in Google Scholar
7. Bombieri C, Pignatti PF. Cystic fibrosis mutation testing in Italy. Genet Test2001;5:229–33.10.1089/10906570152742281Search in Google Scholar
8. Ferec C, Le Marechal C, Audrezet MP, Farinha CM, Amaral MD, Gallati S, et al. Analysis of genomic CFTR DNA. J Cyst Fibros2004;3:7–10.10.1016/j.jcf.2004.05.003Search in Google Scholar
9. Chevalier-Porst F, Souche G, Bozon D. Identification and characterization of three large deletions and deletion/polymorphism in the CFTR gene. Hum Mutat2005;25:504.10.1002/humu.9335Search in Google Scholar
10. Castellani C, Bonizzato A, Cabrini G, Mastella G. Newborn screening strategy for cystic fibrosis: a field study in an area with high allelic heterogeneity. Acta Paediatr1997;86:497–502.10.1111/j.1651-2227.1997.tb08920.xSearch in Google Scholar
11. Castellani C, Picci L, Scarpa M, Dechecchi MC, Zanolla L, Assael BM, et al. Cystic fibrosis carriers have higher neonatal immunoreactive trypsinogen values than non-carriers. Am J Med Genet2005;135A:142–4.10.1002/ajmg.a.30470Search in Google Scholar
12. Foresta C, Ferlin A, Gianaroli L, Dallapiccola B. Guidelines for the appropriate use of genetic tests in infertile couples. Eur J Hum Genet2002;10:303–12.10.1038/sj.ejhg.5200805Search in Google Scholar PubMed
13. Dequeker E, Cassiman JJ. Genetic testing and quality control in diagnostic laboratories. Nat Genet2000;25:259–60.10.1038/77008Search in Google Scholar PubMed
14. Dequeker E, Ramsden S, Grody WW, Stenzel TT, Barton DE. Quality control in molecular genetic testing. Nat Rev Genet2001;2:717–23.10.1038/35088588Search in Google Scholar PubMed
15. Holtzman N, Shapiro D. Genetic testing and public policy. Br Med J1998;316:852–6.10.1136/bmj.316.7134.852Search in Google Scholar PubMed PubMed Central
16. Schwartz M. Genetic testing and the clinical laboratory improvement amendments of 1988: present and future. Clin Chem1999;45:739–45.10.1093/clinchem/45.5.739Search in Google Scholar
17. The Italian National Centre for Rare Diseases. http://www.iss.it/cnmr. Accessed January 15, 2007.Search in Google Scholar
18. Taruscio D, Falbo V, Floridia G, Salvatore M, Pescucci C, Cantafora A, et al. Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance. Clin Chem Lab Med2004;42:915–21.10.1515/CCLM.2004.148Search in Google Scholar PubMed
19. Rendine S, Calafell F, Cappello N, Gagliardini R, Caramia G, Rigillo N, et al. Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution. Ann Hum Genet1997;61:411–24.10.1017/S0003480097006477Search in Google Scholar
20. Database of Italian laboratories performing genetic testing for CF mutation. http://spazioinwind.libero.it/laboratoricf/. Accessed January 15, 2007.Search in Google Scholar
21. Burke W, Zimmern RL. Ensuring the appropriate use of genetic tests. Nat Rev Genet2004;5:955–9.10.1038/nrg1495Search in Google Scholar PubMed
22. Batjer JD. The College of American Pathologists laboratory accreditation program. Clin Lab Haematol1990;12:135–8.Search in Google Scholar
23. Dequeker E, Cuppens H, Dodge J, Estivill X, Goossens M, Pignatti PF, et al. Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis. Eur J Hum Genet2000;8:S2–24.10.1038/sj.ejhg.5200487Search in Google Scholar PubMed
24. Van Loon C, Van Crombruggen J, Azzuz I, Celis L, Bläser M, Timmermans L, et al. Validation of a new line probe assay for the amplification and simultaneous detection of 21 Italian CFTR mutations. Presented at the 28th European Cystic Fibrosis Conference, Crete, June 22–25, 2005.Search in Google Scholar
25. Lemna WK, Feldman GL, Kerem B, Fernbach SD, Zevkovich EP, O'Brien WE, et al. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med1990;322:291–6.10.1056/NEJM199002013220503Search in Google Scholar PubMed
26. Castellani C, Lalatta F, Neri D, Novelli G, Piccinini A, Seia M, et al. Modelli di analisi genetica per fibrosi cistica a cura della Commissione di Studio sulle modalità di analisi genetica per Fibrosi Cistica. http://www.pnlg.it/out/005/005.pdf. Accessed January 15, 2007.Search in Google Scholar
©2007 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Associations between folate, vitamin B12, homocysteine and pathologies related to aging: the need to consider complex nutrient-nutrient and gene-nutrient interactions and the functional and socio-economic determinants in population-based studies
- Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation
- Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily
- Association of thyroid dysfunction with vitamin B12, folate and plasma homocysteine levels in the elderly: a population-based study in Sicily
- Desmond (Des) Kenny MSc MCB FICI FRCPath Eur Clin Chem, 1941–2006
- Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis
- Patient hydration: a major source of laboratory uncertainty
- Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays
- Quantification of relative changes in specific mRNAs from frozen whole blood – methodological considerations and clinical implications
- HER-2 protein concentrations in breast cancer cells increase before immunohistochemical and fluorescence in situ hybridization analysis turn positive
- Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis
- Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis
- Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district: 14-year series
- Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged
- Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
- Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection
- Predicted influence of sample hematocrit on injected mass of internal standard in mass spectrometry assays utilizing simple protein precipitation for sample preparation
- Evaluation of cardiovascular risk factors and related clinical markers in healthy young Japanese adults
- Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography
- Plasma homocysteine cutoff values for venous thrombosis
- Lipid transfer protein activities in subjects with impaired glucose tolerance
- Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia
- Biochemical reference intervals for sex hormones with a new AutoDelfia method in aged men
- The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity
- Standardization of ischemia-modified albumin testing: adjustment for serum albumin
- Is simultaneous measurement of anti-thyroid peroxidase and anti-thyroglobulin antibodies clinically useful in patients with thyroid dysfunction?
- To the Editor: In reply to Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
- To the Editor: Author reply; Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
- Accreditation of medical laboratories in the European Union
- Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
Articles in the same Issue
- Associations between folate, vitamin B12, homocysteine and pathologies related to aging: the need to consider complex nutrient-nutrient and gene-nutrient interactions and the functional and socio-economic determinants in population-based studies
- Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation
- Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily
- Association of thyroid dysfunction with vitamin B12, folate and plasma homocysteine levels in the elderly: a population-based study in Sicily
- Desmond (Des) Kenny MSc MCB FICI FRCPath Eur Clin Chem, 1941–2006
- Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis
- Patient hydration: a major source of laboratory uncertainty
- Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays
- Quantification of relative changes in specific mRNAs from frozen whole blood – methodological considerations and clinical implications
- HER-2 protein concentrations in breast cancer cells increase before immunohistochemical and fluorescence in situ hybridization analysis turn positive
- Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis
- Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis
- Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district: 14-year series
- Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged
- Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
- Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection
- Predicted influence of sample hematocrit on injected mass of internal standard in mass spectrometry assays utilizing simple protein precipitation for sample preparation
- Evaluation of cardiovascular risk factors and related clinical markers in healthy young Japanese adults
- Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography
- Plasma homocysteine cutoff values for venous thrombosis
- Lipid transfer protein activities in subjects with impaired glucose tolerance
- Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia
- Biochemical reference intervals for sex hormones with a new AutoDelfia method in aged men
- The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity
- Standardization of ischemia-modified albumin testing: adjustment for serum albumin
- Is simultaneous measurement of anti-thyroid peroxidase and anti-thyroglobulin antibodies clinically useful in patients with thyroid dysfunction?
- To the Editor: In reply to Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
- To the Editor: Author reply; Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
- Accreditation of medical laboratories in the European Union
- Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
